Oragenics
OGEN
12 hedge funds and large institutions have $3.98M invested in Oragenics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more capital invested
Capital invested by funds: $2.39M → $3.98M (+$1.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
14% less funds holding
Funds holding: 14 → 12 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
+$1.64M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$26.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.69K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$3.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$184K |
| 2 |
Barclays
London,
United Kingdom
|
-$87.4K |
| 3 |
Renaissance Technologies
New York
|
-$76K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$35.6K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18K |
OGEN Hedge Fund Activity: Q1 2020 in Review
12 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2020, worth a combined $3.98M — up 67% from $2.39M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of OGEN and 4 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Third Security, adding an estimated $1.64M. The largest seller was Sabby Management, exiting entirely with an estimated $184K sold.
- 12 institutional investors held Oragenics (OGEN) as of Q1 2020, down from 14 in Q4 2019.
- Funds reported $3.98M of Oragenics stock for Q1 2020, up 67% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q1 2020 and 5 closed out, a net change of -1 holder.
- The largest Oragenics buyer in Q1 2020 was Third Security, an estimated $1.64M added.
- The largest Oragenics seller in Q1 2020 was Sabby Management, an estimated $184K sold.
Based on aggregated 13F filings for Q1 2020.